Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 8;2025(2):e240125.
doi: 10.1530/EDM-24-0125. Print 2025 Apr 1.

Multi-disciplinary collaboration in diagnosing thymic hyperplasia in a Graves' disease patient

Multi-disciplinary collaboration in diagnosing thymic hyperplasia in a Graves' disease patient

Khin Yadanar Kyaw et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Summary: Thymic hyperplasia in Graves' disease is rarely identified due to the absence of routine imaging, but not uncommonly present. It is usually seen when imaging is performed for other reasons. Despite thymic hyperplasia becoming a more commonly identified occurrence, follow-up imaging scans and multi-disciplinary team (MDT) approach are still recommended to distinguish this benign transformation from more significant differentials. These steps can lead to distress in patients. Therefore, clinicians and radiologists being aware of this correlation between thymic hyperplasia and Graves' disease can add reassurances about the most likely diagnosis whilst the patient is undergoing limited further investigation to rule out differentials and subsequently, avoid unnecessary intervention. Here, we report a case of Graves' disease with thymic hyperplasia in a young woman who initially presented with non-specific eye symptoms and incidental mediastinal mass, in which involvement of multiple speciality teams was important to rule out thymoma and myasthenia gravis (MG).

Learning points: Although Graves' disease with thymic hyperplasia is not uncommon, it is sometimes difficult to diagnose with one imaging scan due to the overlap of radiological characteristics of other important differentials; an MDT discussion and further imaging scans are needed to confirm the diagnosis in some cases. Getting MDT involvement early would quickly assist in ruling out more significant differentials and avoid unnecessary surgical intervention by concluding thymic hyperplasia. Clinicians having knowledge on the relation between Graves' disease and thymic hyperplasia may reassure the patient by explaining the possible resolution with treatment, while awaiting further MDT discussion. To rule out ocular MG in Graves' disease patients, additional investigations and neurology referral are often required as the serum antibody tests are less sensitive in ocular MG than generalised MG.

Keywords: Autoimmune; Graves’ disease; Myasthenia Gravis; Thymic hyperplasia; Thyroid.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work reported.

Figures

Figure 1
Figure 1
CT images of homogeneous triangular soft tissue anterior mediastinal mass confined to the anterior mediastinal borders laterally and draped over the pericardium inferiorly, with no evidence of infiltration.
Figure 2
Figure 2
MR images showing significant reduction in thymic size, with a minimal residual soft tissue component, best appreciated on the out of phase sequence.

References

    1. Zelissen PM, Bast EJ & Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995. 8 121–130. ( 10.1006/jaut.1995.0009) - DOI - PubMed
    1. Kotwal N, Singh Y, Menon A, et al. Thymic hyperplasia in Graves' disease. Indian J Endocrinol Metab 2013. 17 521–523. ( 10.4103/2230-8210.111676) - DOI - PMC - PubMed
    1. Gunn A, Michie W & Irvine WJ. The thymus in thyroid disease. Lancet 1964. 2 776–778. ( 10.1016/s0140-6736(64)90558-6) - DOI - PubMed
    1. Shanmugasundaram M, Varadhan L, Katreddy MVR, et al. Thymic hyperplasia and its spontaneous resolution with treatment of Graves’ hyperthyroidism. BMJ Case Rep 2016. 2016 bcr2016215285. ( 10.1136/bcr-2016-215285) - DOI - PMC - PubMed
    1. McIver B & Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 1998. 27 73–89. ( 10.1016/s0889-8529(05)70299-1) - DOI - PubMed

LinkOut - more resources